ClinicalTrials.Veeva

Menu

Ocular Effects of Carotid Endarterectomy

S

Shaare Zedek Medical Center

Status

Unknown

Conditions

Carotid Stenosis
Choroid
Carotid Endarterectomy

Treatments

Device: OCT swept source DRI-Atlantis, Topcon

Study type

Interventional

Funder types

Other

Identifiers

NCT02448355
hanhart1

Details and patient eligibility

About

All patients undergoing carotid endarterectomy in Shaare Zedek Medical Hospital, during about 1 year, will be offered to participate.

Retinal and choroidal structural changes will be assessed using swept-source OCT technology

Enrollment

30 estimated patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Carotid stenosis requiring surgical management

Exclusion criteria

  • Ocular conditions: media opacities precluding fundus visualization, bilateral no-light perception
  • Ocular surgery within 6 months prior to endarterectomy

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Patient undergoing carotid endarterectomy
Experimental group
Description:
All patients undergoing carotid endarterectomy in Shaare Zedek Medical Center Visual acuity measurement (Snellen) SS-OCT (DRI-Atlantis, Topcon) 3-dimensional scanning protocol with 3 μm axial resolution and a speed of 100,000 A-scans per second. 256 B-scans to be taken on an area of 12 × 9 μm. * On pre-op visit (Monday) * Day 1 post-surgery * Discharge day * Week 1 post-surgery * Month 1 post-surgery
Treatment:
Device: OCT swept source DRI-Atlantis, Topcon

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems